PL2632916T3 - Nowe środki przeciwnowotworowe - Google Patents

Nowe środki przeciwnowotworowe

Info

Publication number
PL2632916T3
PL2632916T3 PL11835350T PL11835350T PL2632916T3 PL 2632916 T3 PL2632916 T3 PL 2632916T3 PL 11835350 T PL11835350 T PL 11835350T PL 11835350 T PL11835350 T PL 11835350T PL 2632916 T3 PL2632916 T3 PL 2632916T3
Authority
PL
Poland
Prior art keywords
cancer agents
novel anti
novel
cancer
agents
Prior art date
Application number
PL11835350T
Other languages
English (en)
Inventor
Antony Wilks Burgess
Francesca Walker
Keith Geoffrey Watson
Helen Witchard
Guillaume Lessene
Original Assignee
The Walter And Eliza Hall Institute Of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Walter And Eliza Hall Institute Of Medical Research filed Critical The Walter And Eliza Hall Institute Of Medical Research
Publication of PL2632916T3 publication Critical patent/PL2632916T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL11835350T 2010-10-27 2011-10-27 Nowe środki przeciwnowotworowe PL2632916T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40726510P 2010-10-27 2010-10-27
EP11835350.7A EP2632916B1 (en) 2010-10-27 2011-10-27 Novel anti-cancer agents

Publications (1)

Publication Number Publication Date
PL2632916T3 true PL2632916T3 (pl) 2017-07-31

Family

ID=45992970

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11835350T PL2632916T3 (pl) 2010-10-27 2011-10-27 Nowe środki przeciwnowotworowe

Country Status (12)

Country Link
US (3) US8835629B2 (pl)
EP (1) EP2632916B1 (pl)
JP (2) JP6184866B2 (pl)
KR (1) KR101896924B1 (pl)
CN (1) CN103476769B (pl)
AU (1) AU2011320024B2 (pl)
CA (1) CA2814120C (pl)
ES (1) ES2621932T3 (pl)
HU (1) HUE032522T2 (pl)
NZ (1) NZ609186A (pl)
PL (1) PL2632916T3 (pl)
WO (1) WO2012054978A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103476769B (zh) * 2010-10-27 2016-06-01 沃尔特及伊莱萨霍尔医学研究院 抗癌剂
KR101853785B1 (ko) 2013-11-20 2018-05-02 주식회사 만도 3상모터 제어장치 및 그의 고토크 유지 방법
WO2016070241A1 (en) * 2014-11-03 2016-05-12 Ctxt Pty Ltd Triazine compounds, compositions and synthesis
US20200128829A1 (en) * 2017-06-08 2020-04-30 University Of South Alabama Antimicrobial Compounds
SG11202006246PA (en) 2018-01-17 2020-07-29 Aurigene Discovery Tech Ltd Substituted alkynylene compounds as anticancer agents

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1035771A (pl)
US2742466A (en) 1956-04-17 Chx n nhx c c
US3145203A (en) 1961-11-30 1964-08-18 Geigy Chem Corp Hydrazones of 5-nitro-2-furaldehyde
JPS5277163A (en) 1975-12-24 1977-06-29 Asahi Chem Ind Co Ltd Stabilized polyurethane composition
FR2524467A1 (fr) 1982-03-30 1983-10-07 Adir Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
JPS62192474A (ja) 1986-02-19 1987-08-24 Canon Inc 記録液
US4932998A (en) 1986-09-30 1990-06-12 Idemitsu Kosan Company Limited Triazine derivatives, and herbicides comprising the same as the effective ingredient
US4844731A (en) 1986-12-27 1989-07-04 Idemitsu Company Co., Ltd. Triazine derivatives
US5187045A (en) 1988-09-07 1993-02-16 Minnesota Mining And Manufacturing Company Halomethyl-1,3,5-triazines containing a sensitizer moiety
RO108684B1 (ro) 1989-02-20 1994-07-29 Idemitsu Kosan Co Derivati de s-triazina si compozitie erbicida continandu-i
WO1993010116A1 (en) 1991-11-12 1993-05-27 Pfizer Inc. Triazine derivatives for enhancing antitumor activity
EP0629622B1 (en) 1992-02-28 1998-11-11 Zenyaku Kogyo Kabushikikaisha S-triazine derivative and remedy for estrogen-dependent diseases containing the same as active ingredient
US5574057A (en) * 1993-02-03 1996-11-12 University Of Utah Research Foundation Naamidine A extracted from sea sponges and methods for its use as an anti-tumor agent
US6566384B1 (en) 1996-08-07 2003-05-20 Darwin Discovery Ltd. Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
FR2757056B1 (fr) 1996-12-17 2003-03-14 Oreal Compositions comprenant un derive de dibenzoylmethane, un derive de 1,3,5-triazine et un compose amide et utilisations
FR2757057A1 (fr) 1996-12-17 1998-06-19 Oreal Compositions comprenant un derive de dibenzoylmethane, un derive de 1,3,5-triazine et un derive silicie a fonction benzalmalonate et utilisations
EP0945447A1 (en) 1998-03-27 1999-09-29 Janssen Pharmaceutica N.V. Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections
US6262053B1 (en) 1999-06-23 2001-07-17 Parker Hughes Institute Melamine derivatives as potent anti-cancer agents
EP1333833B1 (en) 2000-10-23 2011-08-24 GlaxoSmithKline LLC Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases
US7173032B2 (en) 2001-09-21 2007-02-06 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
WO2003032903A2 (en) * 2001-10-12 2003-04-24 New York University Trisubstituted triazines compounds with antitubulin activity
CN1697831A (zh) * 2002-09-23 2005-11-16 雷迪美国治疗公司 新三嗪化合物的制备方法和组合物
CN103476769B (zh) * 2010-10-27 2016-06-01 沃尔特及伊莱萨霍尔医学研究院 抗癌剂

Also Published As

Publication number Publication date
WO2012054978A1 (en) 2012-05-03
CA2814120C (en) 2018-08-07
CN103476769A (zh) 2013-12-25
KR20130141554A (ko) 2013-12-26
EP2632916A1 (en) 2013-09-04
EP2632916B1 (en) 2017-01-11
US9221799B2 (en) 2015-12-29
US20160145243A1 (en) 2016-05-26
HUE032522T2 (en) 2017-09-28
CA2814120A1 (en) 2012-05-03
US20150045365A1 (en) 2015-02-12
EP2632916A4 (en) 2014-04-23
CN103476769B (zh) 2016-06-01
US8835629B2 (en) 2014-09-16
AU2011320024A1 (en) 2013-05-02
KR101896924B1 (ko) 2018-09-10
AU2011320024B2 (en) 2014-10-30
JP2013540778A (ja) 2013-11-07
US20130261119A1 (en) 2013-10-03
NZ609186A (en) 2015-08-28
JP2017137323A (ja) 2017-08-10
JP6184866B2 (ja) 2017-08-23
ES2621932T3 (es) 2017-07-05

Similar Documents

Publication Publication Date Title
DK3342786T3 (en) Anti-dll3-antistof
AP3107A (en) 5-Alkynyl-pyrimidines
EP2566479A4 (en) AZA-INDAZOLES
EP2640189A4 (en) 3-deutero-pomalidomide
EP2534256A4 (en) NEW USES
EP2651505A4 (en) ELECTROPORATION-INDUCED ELECTROSENSIBILIZATION
DK3466977T3 (en) Anti-vla-4-antistoffer
EP2641891A4 (en) PKC ACTIVATOR-
EP2583770A4 (en) STRUCTURAL ELEMENT
GB201013207D0 (en) Novel combination
GB201001760D0 (en) Dipenser
PL2632916T3 (pl) Nowe środki przeciwnowotworowe
GB201016912D0 (en) Novel combination
GB201001385D0 (en) Cable-tidies
GB201000196D0 (en) Novel combination
GB201001546D0 (en) Knocktop
GB201015784D0 (en) Anti-cancer compounds
AU4536P (en) TB01 Tibouchina urvilleana
AU4937P (en) FlatinsulGL Myoporum insulare
AU4822P (en) FlatwaxwhiteGL Chamelaucium uncinatum
AU4931P (en) FlatwaxDarkGL Chamelaucium uncinatum
AU4932P (en) FlatwaxpinkGL Chamelaucium uncinatum
GB201002829D0 (en) Novel copmounds
GB201013214D0 (en) Novel combination
GB201013211D0 (en) Novel combination